Baudax Bio to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference Nov 15, 2021 7:00am EST
Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000 Nov 11, 2021 7:00am EST
Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights Nov 04, 2021 7:00am EDT
Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021 Oct 28, 2021 7:00am EDT
Baudax Bio to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sep 16, 2021 7:00am EDT
Baudax Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Sep 07, 2021 7:00am EDT
